Metabolic syndrome is associated with diabetes, heart disease, stroke, and many other health conditions. Kidney disease is a common comorbidity, or consequence, of these diseases. We propose a holistic approach to this entity, Metabolic-associated chronic kidney disease (mCKD). As type 2 diabetes mellitus (T2DM), hypertension, obesity, and related metabolic diseases become more prevalent worldwide, it is increasingly important to identify, categorize, and manage mCKD as a unique phenotype. This review explores the causative factors, clinical manifestations, diagnostic criteria, and curative as well as mitigative approaches for mCKD.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: